Compounds > rofecoxib
Page last updated: 2024-11-04

rofecoxib and Proteinuria

rofecoxib has been researched along with Proteinuria in 2 studies

Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.

Research Excerpts

ExcerptRelevanceReference
"Vitamin D deficiency is common in chronic kidney disease (CKD)."1.38Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease. ( de Borst, MH; de Cuba, MM; Doorenbos, CR; Gans, RO; Kema, IP; Navis, G; van den Born, J; Vogt, L, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vogt, L2
de Zeeuw, D1
Woittiez, AJ1
Navis, G2
Doorenbos, CR1
de Cuba, MM1
Kema, IP1
van den Born, J1
Gans, RO1
de Borst, MH1

Trials

1 trial available for rofecoxib and Proteinuria

ArticleYear
Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:4

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Bloo

2009

Other Studies

1 other study available for rofecoxib and Proteinuria

ArticleYear
Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease.
    The Journal of steroid biochemistry and molecular biology, 2012, Volume: 128, Issue:1-2

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cyclooxygenase Inhibitors; Drug Therapy, Comb

2012